Valentina Ivezaj, PhD
Associate Professor of PsychiatryCards
About
Research
Publications
2026
Examining Heterogeneity of Patient Outcomes in a Randomized Controlled Trial for Binge‐Eating Disorder Testing Cognitive‐Behavioral Therapy and Lisdexamfetamine, Alone and Combined
Yurkow S, Bowman W, Ivezaj V, Grilo C. Examining Heterogeneity of Patient Outcomes in a Randomized Controlled Trial for Binge‐Eating Disorder Testing Cognitive‐Behavioral Therapy and Lisdexamfetamine, Alone and Combined. International Journal Of Eating Disorders 2026 PMID: 42057441, PMCID: PMC13208112, DOI: 10.1002/eat.70115.Peer-Reviewed Original Research
2025
Response to Akçay
Yurkow S, Ivezaj V, Grilo C. Response to Akçay. Obesity 2025, 34: 273-274. PMID: 41371909, DOI: 10.1002/oby.70109.Commentaries, Editorials and LettersPsychometric properties of the Eating loss of control scale in a sample of Hispanic persons seeking metabolic and bariatric surgery
Marek R, Ivezaj V, Parikh M, Jayade M, Lawson J, Grilo C. Psychometric properties of the Eating loss of control scale in a sample of Hispanic persons seeking metabolic and bariatric surgery. Surgery For Obesity And Related Diseases 2025, 22: 99-105. PMID: 41136272, DOI: 10.1016/j.soard.2025.09.009.Peer-Reviewed Original ResearchA prospective assessment of weight bias internalization in patients seeking body contouring after bariatric surgery
Dunford A, Metzler A, Pittman B, Alperovich M, Price G, Ivezaj V. A prospective assessment of weight bias internalization in patients seeking body contouring after bariatric surgery. Surgery For Obesity And Related Diseases 2025, 21: 1350-1356. PMID: 40940272, DOI: 10.1016/j.soard.2025.06.020.Peer-Reviewed Original ResearchCognitive‐Behavioral Therapy and Lisdexamfetamine, Alone and Combined, for Binge‐Eating Disorder: Secondary Outcomes of a Randomized Controlled Trial
Grilo C, Ivezaj V, Yurkow S, Tek C, Gueorguieva R. Cognitive‐Behavioral Therapy and Lisdexamfetamine, Alone and Combined, for Binge‐Eating Disorder: Secondary Outcomes of a Randomized Controlled Trial. International Journal Of Eating Disorders 2025, 58: 1970-1978. PMID: 40631364, PMCID: PMC12268943, DOI: 10.1002/eat.24502.Peer-Reviewed Original ResearchIs there harm in behavioral weight loss for binge-eating disorder: Controlled comparison to cognitive behavioral therapy
Grilo C, Yurkow S, White M, Lydecker J, Ivezaj V. Is there harm in behavioral weight loss for binge-eating disorder: Controlled comparison to cognitive behavioral therapy. General Hospital Psychiatry 2025, 96: 72-74. PMID: 40543449, PMCID: PMC13101889, DOI: 10.1016/j.genhosppsych.2025.06.005.Commentaries, Editorials and LettersIs there harm in behavioral lifestyle weight management for binge-eating disorder in patients with obesity: Findings from a randomized controlled trial
Grilo C, Ivezaj V, Yurkow S, Lydecker J. Is there harm in behavioral lifestyle weight management for binge-eating disorder in patients with obesity: Findings from a randomized controlled trial. Journal Of Psychosomatic Research 2025, 195: 112169. PMID: 40516275, PMCID: PMC12255517, DOI: 10.1016/j.jpsychores.2025.112169.Peer-Reviewed Original ResearchPreferences for Lisdexamfetamine vs Cognitive-Behavioral Therapy for Binge-Eating Disorder: Correlates and Outcomes.
Yurkow S, Ivezaj V, Pittman B, Grilo C. Preferences for Lisdexamfetamine vs Cognitive-Behavioral Therapy for Binge-Eating Disorder: Correlates and Outcomes. The Journal Of Clinical Psychiatry 2025, 86 PMID: 40338285, DOI: 10.4088/jcp.24m15552.Peer-Reviewed Original ResearchLifestyle behavioral weight‐loss treatment for binge‐eating disorder in patients with obesity: where's the harm?
Yurkow S, Ivezaj V, Grilo C. Lifestyle behavioral weight‐loss treatment for binge‐eating disorder in patients with obesity: where's the harm? Obesity 2025, 33: 1058-1066. PMID: 40342236, PMCID: PMC12119222, DOI: 10.1002/oby.24289.Peer-Reviewed Original Research
2024
Cognitive Behavioral Therapy and Lisdexamfetamine, Alone and Combined, for Binge-Eating Disorder With Obesity: A Randomized Controlled Trial
Grilo C, Ivezaj V, Tek C, Yurkow S, Wiedemann A, Gueorguieva R. Cognitive Behavioral Therapy and Lisdexamfetamine, Alone and Combined, for Binge-Eating Disorder With Obesity: A Randomized Controlled Trial. American Journal Of Psychiatry 2024, 182: 209-218. PMID: 39659158, PMCID: PMC11786997, DOI: 10.1176/appi.ajp.20230982.Peer-Reviewed Original Research
Clinical Trials
Current Trials
Treatments to Treat Loss-of-Control Eating and Improve Weight Outcomes after Bariatric Surgery
IRB ID2000029057RoleSub InvestigatorPrimary Completion Date11/30/2027Recruiting ParticipantsCognitive-Behavioral Therapy for Girls Who Experienced Weight-related Bullying
IRB ID2000028551RoleSub InvestigatorPrimary Completion Date08/31/2022Recruiting ParticipantsGenderFemaleAge11 years - 17 yearsTeen Binge Eating Study
IRB ID2000024926RoleSub InvestigatorPrimary Completion Date02/28/2020Recruiting ParticipantsGenderBothAge13 years - 17 years
News
News
- September 23, 2025Source: San Diego Union-Tribune Online
They've dropped the weight. But what about the skin?
- December 11, 2024Source: The American Journal of Psychiatry
Cognitive Behavioral Therapy and Lisdexamfetamine, Alone and Combined, for Binge-Eating Disorder With Obesity: A Randomized Controlled Trial
- October 24, 2024Source: Cambridge University Press
Lisdexamfetamine Maintenance Treatment for Binge-Eating Disorder Following Successful Treatments
- April 12, 2024
Yurkow Honored For Best Original Research Paper By An Early Career Scholar